There was no difference in major cardiovascular outcomes with the use of two different diuretics — chlorthalidone or hydrochlorothiazide — in the treatment of hypertension in a new large randomized ...

Panelists discuss how diuretics serve as necessary “bailout therapy” for volume management in heart failure but should not substitute for guideline-directed medical therapy, with emerging evidence ...

A common diuretic wasn't much help for staving off recurrent kidney stones, the NOSTONE trial showed. Over a median follow-up of 2.9 years, symptomatic or radiologic recurrence of kidney stones ...

Calcium channel blockers (CCBs) and ACE inhibitors may be no better than diuretics at preventing cardiovascular deaths in patients with hypertension, according to a follow-up study of patients in a ...

Study findings challenge standard use of thiazide and thiazide-like diuretic agents to reduce the risk of kidney stone recurrence. The thiazide diuretic hydrochlorothiazide does not prevent kidney ...

Johna Burdeos is a family mom, registered dietitian and freelance writer. Having provided nutrition care to many patients with acute and chronic medical conditions over the years, Johna is passionate ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up Newswise — A research study of more than 600 black patients ...

Some foods and drinks like watermelon, coffee and tea can help flush out excess fluid. Natural diuretics work by reducing sodium, which pulls water out of the body with it. Too much fluid can be ...

Please provide your email address to receive an email when new articles are posted on . In a cross-sectional analysis, researchers examined 176,448 adults receiving center-based maintenance ...

The NFL suspended Arizona Cardinals wide receiver DeAndre Hopkins on May 2 for six games for violating the league's policy on performance-enhancing substances. Amid its statement on the matter, the ...

Industry marketing for angiotensin receptor–neprilysin inhibitors (ARNis) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) targeted at cardiologists was associated with increased prescription ...